Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Cohen Chad M
Relationship:   Director
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   230,845    

Indirect Shares

   0      
Direct Value   $176,620    

Indirect Value

   $0      
Total Shares   230,845      
Total Value   $176,620      


Zillow Group Inc $7,598 Trupanion Inc. $0 Adaptive Biotechnologies Corp $74,750 Vacasa, Inc. $94,272 Zillow Group Inc $7,598 Trupanion Inc. $0 Adaptive Biotechnologies Corp $74,750 Vacasa, Inc. $94,272
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 44.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Zillow Group Inc Z CFO & Treasurer 2015-02-18 183 2015-02-17 0    Premium*  
            Trupanion Inc. TRUP Director 2019-03-31 4,119 2018-03-31 0    Premium*  
            Adaptive Biotechnologies Corp ADPT Chief Financial Officer 2021-12-22 21,604 2019-07-01 0    Premium*  
            Vacasa, Inc. VCSA Director 2023-05-23 204,939 2022-05-24 0    Premium*  
* Premium Members only  

Records found :    109         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-20 4 OE $6.32 $316,000 D/D 50,000 51,000 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-25 4 AS $65.08 $3,303,382 D/D (50,000) 1,000 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-25 4 OE $6.32 $316,000 D/D 50,000 51,000 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-26 4 AS $62.71 $3,202,074 D/D (50,000) 1,000 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-26 4 OE $6.32 $316,000 D/D 50,000 51,000 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-28 4 OE $6.32 $316,000 D/D 50,000 51,000 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-28 4 AS $55.04 $2,811,055 D/D (50,000) 1,000 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-29 4 AS $55.77 $2,801,546 D/D (50,000) 1,000 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-01-29 4 OE $6.32 $316,000 D/D 50,000 51,000 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-03-04 4 A $0.00 $0 D/D 20,604 21,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-03-09 4 AS $40.02 $402,425 D/D (10,000) 21,064 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-03-09 4 OE $6.32 $63,200 D/D 10,000 31,064 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-03-10 4 OE $6.32 $63,200 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-03-10 4 AS $42.54 $425,400 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-04-06 4 OE $6.32 $63,200 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-04-06 4 AS $40.95 $409,500 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-04-07 4 OE $6.32 $63,200 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-04-07 4 AS $41.59 $416,505 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-05-11 4 AS $30.81 $315,342 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-05-11 4 OE $6.55 $65,500 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-05-12 4 AS $32.63 $326,300 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-05-12 4 OE $6.55 $65,500 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-06-08 4 OE $6.55 $65,500 D/D 10,000 31,604 0 -
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-06-08 4 AS $36.90 $370,519 D/D (10,000) 21,604 0 %
ADPT Adaptive Biotechnologies ... Chief Financial Officer   •       –      –    2021-06-09 4 OE $6.55 $65,500 D/D 10,000 31,604 0 -
  109  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us